Elanco Animal Health Incorporated (ELAN) — closed signal from August 27, 2025
Target reached Published before the outcome was known, scored automatically when the window closed on November 25, 2025 — +25.4% at the close.
Predicted vs. what happened
What happened
Reached its target in 89 days.
The thesis — published August 27, 2025
Elanco may get a short boost as it joins the S&P MidCap 400 on 2025-09-02. When a stock enters an index, funds that track it often must buy, which can lift prices, but pullbacks after the change are common. Buying near $18.25-$18.80 aims to catch late demand, but the business looks weak, so keep risk tight and react fast. We will watch trading before and after the event.
Primary drivers
- Index addition set; S&P MidCap 400 entry effective on 2025-09-02.
- Near-term automatic buying from index-tracking funds may lift demand.
- Recent price strength suggests buyers are in control for now, but can fade.
- Company fundamentals look weak, so gains may not last after the event.
How it played out
ELAN: target reached in 89 days
Lyra published ELAN at $18.68 on 2025-08-27, with an entry zone of $18.25 to $18.80 and expected growth of 24%. The thesis pointed to Elanco joining the S&P MidCap 400 on 2025-09-02, possible buying from index-tracking funds, recent price strength, and the risk that gains could fade because the business looked weak.
Inside the window, ELAN reached the $23.17 target. Its peak was $23.59 on 2025-11-25, with a peak gain of 26.3%. The target was reached in 89 days. The stock ended at $23.43. The thesis played out on price.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Share this receipt
A scored call, published before the outcome was known. Paste the link anywhere — it unfurls as the card above.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.